The Brazilian Health Regulatory Agency (Anvisa) recently inspected Caplin Steriles’ injectable and ophthalmic manufacturing facility in Gummidipoondi from August 12 to 16. The inspection concluded successfully with zero observations.
Can Lumino Industries IPO deliver long-term growth for high-risk investors?
Lumino Industries plans a ₹700 crore initial public offering to reduce debt and boost manufacturing capacity. The company expects to benefit from increased demand for